首页 正文

Identification and evaluation of a lipid-lowering small compound as a PCSK9 inhibitor

{{output}}
Introduction: Hyperlipidemia is a key contributor to cardiovascular diseases, underscoring the necessity for alternative lipid-lowering treatments beyond statins. ... ...